The French drugmakers have launched groundbreaking medicines for Gaucher disease, Pompe disease, Fabry disease, mucopolysaccharidosis I (MPS I) and acid…
We are now clearly seeing an opportunity to penetrate into tier two, tier three cities and maybe even go into…
With a focus on disease areas like Type 1 Diabetes, Type 2 Diabetes, Obesity, Hemophilia, Sickle-Cell Anemia, Cardiovascular diseases and…
Digital therapeutics (DTx) is a rapidly evolving field that leverages technology to prevent, treat or manage medical conditions, Srinivasan told…
It’s a reality that 90 percent of Indians have some form of dental disease, Singh told Financial Express.com.
In the Indian healthcare paradigm, challenges like limited access to quality care in remote areas and distrust in healthcare systems…
India offers international standard healthcare at a much more reasonable cost than anywhere else in the world, Dr. Prabhakaran told…
Key advancements centre on immune checkpoint inhibitors, heralding a transformative era in oncology through immunotherapy, Madhavan told Financial Express.com.
The developing landscape of beauty supplements in India focuses a greater emphasis on holistic well-being and the necessity of nutrition…
Despite the many strides that have been made in enabling access women’s healthcare needs, limited access to information, tools, resources,…
Public-Private Partnerships (PPPs) have played a significant role in expanding access to quality cancer care in India, Sachdeva told Financial…
As a leader in dermatology, we have actively sought opportunities to leverage our know-how and establish our presence across the…
To sustain and enhance this positive momentum, it’s crucial to expand offerings beyond basic generics, Veeramani told Financial Express.com.
In India, roughly 67,385 babies are born each day. Unfortunately, there are 28 newborn deaths for every 1,000 live births;…
Recently, the Access to Nutrition Initiative (ATNI), a global independent non-profit organization dedicated to catalyzing market transformation for enhanced access…
He also pointed out that there is a need to create an environment where healthier options are available.
A 2022 study has revealed that stigma associated with asthma is preventing patients from getting the right treatment in India.
One major challenge is to provide quality access because we need our products to reach much deeper to tier 2…